SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  September 16, 2003

Specialty Laboratories, Inc.

(Exact name of registrant as specified in its charter)

 

California

(State or other jurisdiction of incorporation)

 

001-16217

 

95-2961036

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

2211 Michigan Avenue Santa Monica, California

 

90404

Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (310) 828-6543

 

Not applicable

(Former name or former address, if changed since last report)

 



Item 5.  Other Events and Regulation FD Disclosure.

On September 16, 2003, Specialty Laboratories, Inc., (the “Registrant”) announced that Terrance H. Gregg has resigned from our Board of Directors.  A copy of the press release issued by the Registrant on September 16, 2003 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

Item 7.  Financial Statements and Exhibits

 

(c)

 

Exhibits

 

The following document is filed as an exhibit to this report:

 

 

 

99.1

 

Press Release dated September 16, 2003.

 

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Specialty Laboratories, Inc. has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized, in the City of Santa Monica, State of California, on September 16, 2003.

 

SPECIALTY LABORATORIES, INC.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Frank J. Spina

 

 

Frank J. Spina

 

 

Chief Financial Officer